SOCIETE DE PROMOTION PHARMACEUTIQUE DU MAGHREB S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 975 MAD | +3.61% |
|
-0.12% | -2.50% |
| Sales 2021 | 630M 0 | Sales 2022 | 705M 0 | Capitalization | 1.07B 0 |
|---|---|---|---|---|---|
| Net income 2021 | 69M - | Net income 2022 | 75M - | EV / Sales 2021 | 1.48 x |
| Net cash position 2021 | 205M 0 | Net cash position 2022 | 56.78M 0 | EV / Sales 2022 | 1.44 x |
| P/E ratio 2021 |
16.5
x | P/E ratio 2022 |
14.2
x | Employees | - |
| Yield 2021 |
3.51% | Yield 2022 |
3.75% | Free-Float | 5.88% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +3.61% | ||
| 1 week | -0.12% | ||
| Current month | +3.17% | ||
| 1 month | +1.87% | ||
| 3 months | -2.40% | ||
| 6 months | -2.79% | ||
| Current year | -2.50% |
1 week
941.00
975.00
1 month
921.00976.20
Current year
921.001 008.00
1 year
921.001 110.00
3 years
800.001 226.00
5 years
690.001 226.00
10 years
634.001 690.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Said El Bouachi
DFI | Director of Finance/CFO | - | - |
Amine Alaoui
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ma’moun Araidah
CHM | Chairman | - | - |
Khalid Janahi
BRD | Director/Board Member | - | - |
Issam Maguiri
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 975 | +3.61% | 24 |
| 24-04-23 | 941 | -3.61% | 8 |
| 24-04-17 | 976.2 | +5.99% | 52 |
| 24-04-16 | 921 | -3.05% | 1 |
End-of-day quote Casablanca S.E., April 23, 2024
More quotes
Promopharm (Société de Promotion Pharmaceutique du Maghreb) specializes in manufacturing and marketing pharmaceutical, para-pharmaceutical, and cosmetic products. The group also offers subcontractor manufacturing services for pharmaceutical specialties for Moroccan and foreign laboratories. The group's activity is organized primarily around 2 areas:
- sales of drugs: products manufactured under its own name and under license;
- importing and sales of semi-finished products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -2.50% | 92.93M | |
| +18.59% | 42.77B | |
| +19.78% | 22.23B | |
| +13.12% | 14.44B | |
| +11.79% | 13.05B | |
| +35.81% | 11.59B | |
| -9.08% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.29% | 4.97B |
- Stock Market
- Equities
- PRO Stock
